title: Symmetrical Intertriginous and Flexural Exanthema due to Bortezomib (a Proteasome Inhibitor) Given for Myeloma.
authors.affiliation: Department of Dermatology, Montpellier University Hospital, FR-34295 Montpellier, France.
authors.forename: Nausicaa
authors.initials: N
authors.lastname: Malissen
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Bourrain
authors.forename: Anca
authors.initials: A
authors.lastname: Chiriac
authors.forename: Aline
authors.initials: A
authors.lastname: Montet
authors.forename: Laure
authors.initials: L
authors.lastname: Vincent
authors.forename: Olivier
authors.initials: O
authors.lastname: Dereure
authors.forename: Aurélie
authors.initials: A
authors.lastname: Du-Thanh
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D000069286:Bortezomib / Q000009:adverse effects*; D003875:Drug Eruptions; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D061988:Proteasome Inhibitors / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D061988:Proteasome Inhibitors; D000069286:Bortezomib